767 related articles for article (PubMed ID: 24334314)
1. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
2. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
Kübler D; Schroll H; Buchert R; Kühn AA
J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
[TBL] [Abstract][Full Text] [Related]
3. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
4. Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.
Christopher L; Duff-Canning S; Koshimori Y; Segura B; Boileau I; Chen R; Lang AE; Houle S; Rusjan P; Strafella AP
Ann Neurol; 2015 Feb; 77(2):269-80. PubMed ID: 25448687
[TBL] [Abstract][Full Text] [Related]
5. [
Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO
Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577
[TBL] [Abstract][Full Text] [Related]
6. Graph theory analysis of the dopamine D2 receptor network in Parkinson's disease patients with cognitive decline.
Mihaescu AS; Kim J; Masellis M; Graff-Guerrero A; Cho SS; Christopher L; Valli M; Díez-Cirarda M; Koshimori Y; Strafella AP
J Neurosci Res; 2021 Mar; 99(3):947-965. PubMed ID: 33271630
[TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.
Sawamoto N; Piccini P; Hotton G; Pavese N; Thielemans K; Brooks DJ
Brain; 2008 May; 131(Pt 5):1294-302. PubMed ID: 18362097
[TBL] [Abstract][Full Text] [Related]
8. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
[TBL] [Abstract][Full Text] [Related]
9. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
10. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
[TBL] [Abstract][Full Text] [Related]
11. Axonal degeneration in Parkinson's disease - Basal ganglia circuitry and D2 receptor availability.
Pelzer EA; Melzer C; Schönberger A; Hess M; Timmermann L; Eggers C; Tittgemeyer M
Neuroimage Clin; 2019; 23():101906. PubMed ID: 31254937
[TBL] [Abstract][Full Text] [Related]
12. Nigrostriatal and Mesolimbic D
Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
[TBL] [Abstract][Full Text] [Related]
13. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
[TBL] [Abstract][Full Text] [Related]
14. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
15. Extra-striatal dopamine in Parkinson's disease with rapid eye movement sleep behavior disorder.
Valli M; Cho SS; Masellis M; Chen R; Koshimori Y; Diez-Cirarda M; Mihaescu A; Christopher L; Strafella AP
J Neurosci Res; 2021 Apr; 99(4):1177-1187. PubMed ID: 33470445
[TBL] [Abstract][Full Text] [Related]
16. Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
Scherfler C; Khan NL; Pavese N; Eunson L; Graham E; Lees AJ; Quinn NP; Wood NW; Brooks DJ; Piccini PP
Brain; 2004 Jun; 127(Pt 6):1332-42. PubMed ID: 15090472
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in schizophrenia is associated with prefrontal-striatal functional hypoconnectivity and striatal dopaminergic abnormalities.
Yang KC; Yang BH; Liu MN; Liou YJ; Chou YH
J Psychopharmacol; 2024 Jun; 38(6):515-525. PubMed ID: 38853592
[TBL] [Abstract][Full Text] [Related]
19. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
20. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
Ballard ME; Dean AC; Mandelkern MA; London ED
PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
